• Privacy Policy
  • Terms & Conditions
Top Stocks Insider
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Top Stocks Insider
No Result
View All Result
Home News

Pfizer Faces Lawsuit for Covid Vaccine Lies

by
December 7, 2023
in News
0
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On this episode of Radio Rothbard, Ryan McMaken and Tho Bishop are joined by Dr. Gilbert Berdine, an associate professor of medicine at Texas Tech University Health Sciences Center and an affiliate of the Free Market Institute at Texas Tech University. In 2020, Dr. Berdine was warning about efficacy and risks claims being made over covid vaccines, which are at the forefront of a recent lawsuit by the State of Texas against Pfizer. Ryan and Tho discuss the case with Dr. Berdine, as well as the lessons learned from the government’s response to covid and what is fueling the authoritarian capture of the American medical industry.

“What the Covid Vaccine Hype Fails to Mention” by Gilbert Berdine: Mises.org/RR_163_A

“United Kingdom Mortality Data by Age Group and Vaccination Status: Looking at Vaccine Effectiveness” by Gilbert Berdine: Mises.org/RR_163_B

“Real Scientific Inquiry Requires Dissent. But That’s Not What the CDC and JAMA Want.” by Gilbert Berdine: Mises.org/RR_163_C

“Can Austrian Economics Save Medicine?” by DR. MICHEL ACCAD: Mises.org/RR_163_D

Claim your free book: Mises.org/RothPodFree

Be sure to follow Radio Rothbard at Mises.org/RadioRothbard.

Radio Rothbard mugs are now available at the Mises Store. Get yours at Mises.org/RothMug 

PROMO CODE: RothPod for 20% off

Previous Post

Defund the (Diversity) Police

Next Post

Lew Rockwell on NOW with Bill Moyers

Next Post

Lew Rockwell on NOW with Bill Moyers

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Disclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 TopStocksInsider. All Rights Reserved.

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2024 TopStocksInsider. All Rights Reserved.